Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Journal of Immunology (Baltimore, Md. : 1950)|March 8, 2005
Heat shock protein 60 inhibits Th1-mediated hepatitis model via innate regulation of Th1/Th2 transcription factors and cytokinesAlexandra Zanin-Zhorov, Rafael Bruck, Guy Tal, et al.
Pediatric Research|April 30, 2002
Effect of heparin on tissue binding activity of fibroblast growth factor and heparin-binding epidermal growth factor in experimental colitis in ratsArie Levine, Gabriel Kenet, Rafael Bruck, et al.
Archives of Gynecology and Obstetrics|May 21, 2003
Positive serology for Helicobacter pylori and vomiting in the pregnancyHaim Shirin, Oscar Sadan, Orit Shevah, et al.
Journal of Hepatology|December 16, 2003
Melatonin inhibits nuclear factor kappa B activation and oxidative stress and protects against thioacetamide induced liver damage in ratsRafael Bruck, Hussein Aeed, Yona Avni, et al.
Journal of Hepatology|January 24, 2004
Halofuginone, an inhibitor of collagen synthesis by rat stellate cells, stimulates insulin-like growth factor binding protein-1 synthesis by hepatocytesYulia Gnainsky, Gadi Spira, Melia Paizi, et al.
The Israel Medical Association Journal : IMAJ|July 13, 2006
Graft survival and its determinants: a 3 year national experience with liver transplantation in IsraelAnat Ekka-Zohar, Yana Zitser-Gurevich, Micha Mandel, et al.
The American Journal of Pathology|November 15, 2016
Sortilin Deficiency Reduces Ductular Reaction, Hepatocyte Apoptosis, and Liver Fibrosis in Cholestatic-Induced Liver InjuryEinav Hubel, Ashish Saroha, Woo-Jae Park, et al.
BMC Infectious Diseases|April 5, 2020
Ombitasvir/paritaprevir/ritonavir & dasabuvir ± ribavirin following protease inhibitors failure - a prospective multi-centre trialLiat Deutsch, Inbal Houri, Ziv Ben-Ari, et al.
World Journal of Gastroenterology|March 30, 2016
Daclatasvir vs telaprevir plus peginterferon alfa/ribavirin for hepatitis C virus genotype 1Ira Jacobson, Stefan Zeuzem, Robert Flisiak, et al.
Journal of Hepatology|June 14, 2019
Sofosbuvir/velpatasvir for 12 weeks in hepatitis C virus-infected patients with end-stage renal disease undergoing dialysisSergio M Borgia, Janet Dearden, Eric M Yoshida, et al.
Pageof 3